How Stress Circuits Hijack The Brain And Trigger Addiction Relapse
Stress is one of the most powerful relapse triggers in recovery. Here is how the brain's stress circuits hijack motivation, why relapse becomes relief-seeking, and what lowers the risk.
How Is NAD+ Used In Addiction Treatment, And Why Might It Help?
NAD+ therapy aims to restore the cellular energy and repair systems that addiction depletes. Here is how it is used in detox and recovery, what the evidence shows, and why it works best as an adjunct.
GLP-1 Therapy and Methamphetamine Recovery: What Early Research Suggests
An evidence-based look at what early research does, and does not, suggest about GLP-1 therapy such as semaglutide for methamphetamine use disorder.
GLP-1 Medications and Cocaine Addiction treatment: What We Know So Far.
An evidence-based look at what current research does, and does not, show about GLP-1 medications such as semaglutide for cocaine use disorder.
How Does Somatic Experiencing Treat Trauma And Addiction?
Somatic Experiencing treats trauma and addiction through the body, calming a dysregulated nervous system so cravings and triggers lose their grip. Here is how it works and where it fits.
EMDR For Co-Occurring Trauma And Addiction: How Memory Reprocessing Reduces Triggers And Cravings
EMDR therapy helps people with co-occurring trauma and addiction by reprocessing the memories that drive cravings, lowering the emotional charge behind triggers and reducing relapse risk.
Addiction Is Not A Choice: How The Brain Becomes Compulsively Wired
Addiction is not a failure of willpower. Learn how repeated substance use rewires the brain's reward, habit, and control circuits, and how treatment uses that same plasticity to rebuild control.
Why GLP-1 Alone Is Not Enough for Addiction Recovery
Why GLP-1 Alone Is Not Enough for Addiction Recovery Medically Reviewed by Dr. Kenneth Spielvogel, MD, Senior Medical Officer at Carrara Treatment Is a GLP-1 medication alone sufficient for lasting addiction recovery? While GLP-1 receptor agonists like semaglutide effectively...
How GLP-1 Drugs Affect Dopamine and Reward Pathways
How GLP-1 Drugs Affect Dopamine and Reward Pathways Medically Reviewed by Dr. Kenneth Spielvogel, MD, Senior Medical Officer at Carrara Treatment How do GLP-1 receptor agonists suppress substance cravings in the brain? Research reveals that these medications reach deep...
The Future of GLP-1 Medications in Addiction Medicine
The Future of GLP-1 Medications in Addiction Medicine Medically Reviewed by Dr. Kenneth Spielvogel, MD, Senior Medical Officer at Carrara Treatment What is the future of GLP-1 medications in addiction medicine? While drugs like semaglutide and tirzepatide are currently...
